Search clinical trials for: Post-marketing Study

Total 118771 results

Changchun BCHT Biotechnology Co.
Hu Bei province Center for Disease control and prevention; The Inner Mongolia...

Recruiting

Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine

Influenza Prevention

China
Hua Medicine Limited
Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

Recruiting

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Type2diabetes

China
Taizhou Mabtech Pharmaceutical Co.,Ltd

Recruiting

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Crohn Disease

China
Bristol-Myers Squibb
PPD

Recruiting

A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer (PROSPECT-ESO)

Esophageal Carcinoma | Gastroesophageal Junction Carcinoma

United States, Germany
Gruppo Bioimpianti S.r.l.

Recruiting

Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery

Arthropathy of Hip

France
Zhejiang Zylox Medical Device Co., Ltd.

Recruiting

Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia (UltraFuture I)

Peripheral Arterial Disease (PAD)

China
Zhong Wang
Shanxi Zhendong Pharmacy Co., Ltd

Recruiting

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
Novartis Pharmaceuticals

Recruiting

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Fascioliasis

Vietnam, Egypt, Colombia, Peru
Zhong Wang

Recruiting

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Adverse Drug Event | Adverse Drug Reactions | Severe Adverse Reactions | Anaphylactic Reaction

China
Pfizer

Active, not recruiting

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

COVID-19 | SARS-CoV-2

Japan
GlaxoSmithKline

Completed

Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

Influenza, Human

Korea, Republic of
Maxigen Biotech Inc.

Completed

HealiAid in the Treatment of Different Wounds

Burn Wound | Venous Ulcers | Bedsores | Diabetic Foot Wound
Bayer

Completed

Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH) (JPMS-PAH)

Hypertension, Pulmonary

Japan
Bayer

Completed

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Hypertension, Pulmonary

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)

Inoperable or Recurrent Breast Cancer

Japan
Pfizer

Completed

Drug Use Investigation of COMIRNATY Intramuscular Injection

COVID-19

Japan
Pfizer

Completed

Special Investigation of COMIRNATY in the Population With Underlying Diseases

COVID-19

Japan
Organon and Co

Completed

Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647)

Hypercholesterolemia
Organon and Co

Completed

Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)

Contraception
Kamada, Ltd.
Kedrion S.p.A.

Completed

Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies

Rabies

United States
Pfizer

Completed

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Hong Kong, United States, Spain, Israel, Finland, Thailand, Turkey, Taiwan, Poland, Czechia, Malaysia, South Africa, Mexico, China, Australia, Slovakia, United Kingdom, New Zealand, Jordan, Canada, Netherlands, Brazil, Colombia, Puerto... and more
AbbVie

Completed

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Non-infectious Intermediate, Posterior and Panuveitis

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer

Stomach Ulcer

Japan
Zhong Wang

Suspended

Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

Adverse Drug Event | Adverse Drug Reaction | Chinese Medicine | Anaphylactic Reaction

China
Bayer

Completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea (J-MIRAI)

Menorrhagia, Dysmenorrhea

Japan
Eisai Inc.

Completed

A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Japan
GlaxoSmithKline

Completed

Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting

Asthma

Korea, Republic of
AbbVie

Completed

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea (ped PsO rPMS)

Psoriasis

Korea, Republic of
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Thyroid Neoplasms

Japan
GE Healthcare

Completed

Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination

Magnetic Resonance Imaging (MRI)

Germany, Norway
Golden Jubilee National Hospital
Stryker GI Ltd.

Enrolling by invitation

Post-marketing Surveillance Study of the Triathlon Tritanium Baseplate

Arthritis

United Kingdom
Sichuan Baili Pharmaceutical Co., Ltd.
Peking University First Hospital; Beijing Hospital

Unknown

Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection

Ventricular Fibrillation | Ventricular Tachycardia

China
Astellas Pharma Inc

Completed

Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment

Restless Legs Syndrome (RLS)

Japan
Eisai Inc.
Eisai Co., Ltd.

Completed

Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism

Pulmonary Embolism

Japan
Zhong Wang
Shanxi Zhendong pharmaceutical Co. LTD.

Completed

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Adverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse Reactions

China
GlaxoSmithKline
The Organization of Teratology Information Specialists

Terminated

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

Infections, Papillomavirus

United States
Mitsubishi Tanabe Pharma Corporation
Kyowa Kirin Co., Ltd.

Completed

Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

Stroke

Japan
Guerbet

Completed

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Contrast-enhanced MRI With Dotarem
Bristol-Myers Squibb

Completed

Post-marketing Study Assessing the Long-Term Safety of Abatacept

Rheumatoid Arthritis
GlaxoSmithKline

Completed

Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine

Influenza

Czech Republic
AbbVie (prior sponsor, Abbott)

Completed

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice (IDEA)

Ankylosing Spondylitis
AbbVie (prior sponsor, Abbott)

Completed

Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)

Rheumatoid Arthritis
Yung Shin Pharm. Ind. Co., Ltd.
National Cheng-Kung University Hospital; Tri-Service General Hospital; Taichung...

Completed

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Squamous Cell Carcinoma of the Head and Neck | Nonsmall Cell Lung Cancer
GlaxoSmithKline

Terminated

Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines

Infections, Streptococcal

Philippines
Janssen Pharmaceutica

Withdrawn

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Prostate Neoplasms
Janssen Pharmaceutica

Withdrawn

A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis
Peking University Third Hospital
Peking University; Shanghai Greenvalley Pharmaceutical Co., Ltd.

Completed

Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study

Adverse Drug Reaction

China
Merck Sharp & Dohme LLC

Completed

Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261) (SUPPORT)

Substance Abuse, Intravenous | Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott)

Completed

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Psoriatic Arthritis | Ankylosing Spondylitis
Merck Sharp & Dohme LLC

Terminated

Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)

Hepatitis C | Hepatitis C, Chronic

3

Subscribe